Literature DB >> 23791160

Reconstruction of the superior vena cava by biologic conduit: assessment of long-term patency by magnetic resonance imaging.

Antonio D'Andrilli1, Carlo N De Cecco, Giulio Maurizi, Giuseppe Muscogiuri, Rossella Baldini, Vincenzo David, Federico Venuta, Erino A Rendina.   

Abstract

BACKGROUND: To assess the long-term patency of the biologic prosthetic conduit used for reconstruction of the superior vena cava (SVC) by magnetic resonance imaging (MRI).
METHODS: Patients undergoing oncologic resection and reconstruction of the SVC by a bovine pericardial prosthesis (January 2003 to April 2010) have been studied after 1 year (if surviving) by MRI for the assessment of the conduit long-term patency. Results were compared with those of a control group of patients with normal SVC. Blood flow and area of lumen section at 3 different levels (proximal, middle, distal) were analyzed.
RESULTS: Sixteen consecutive patients surviving after 1 year from surgery out of 17 (9 lung cancer, 8 mediastinal malignancy) undergoing SVC reconstruction were included. One patient died postoperatively and was not included. Sixteen patients with similar demographic characteristics were studied in the control group. Mean blood flow was 18.4±3.5 mL/sec (range 14.3 to 25.7) in patients with reconstructed SVC and 20.8±4.1 mL/sec (range 15.3 to 27.7) in the control group. Mean area of the conduit lumen section was 2.2±0.6 cm2 (range 1.6 to 3.6) at proximal level, 2.9±1.3 cm2 at middle level (range 1.3 to 5.7), and 2.1±0.9 cm2 (range 0.5 to 4) at distal level in the reconstructed group, and 2.6±0.7 cm2 (range 1.8 to 4.2), 2.7±0.7 cm2 (range 1.9 to 4.3), and 2.4±0.3 cm2 (range 1.8 to 3.1), respectively, at proximal, middle, and distal levels in the control group. Differences between the 2 groups were not significant (p>0.05).
CONCLUSIONS: The MRI assessment in terms of blood flow and area of lumen section at 3 different levels confirms that bovine pericardial conduit used for SVC replacement shows an optimal patency over the long term.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  10

Mesh:

Year:  2013        PMID: 23791160     DOI: 10.1016/j.athoracsur.2013.04.062

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Commentary: Superior vena cava reconstruction techniques.

Authors:  Nathan Haywood; Irving L Kron
Journal:  JTCVS Tech       Date:  2020-10-29

2.  Total superior vena cava reconstruction guided by preoperative three-dimensional (3D)-computed tomography bronchography and angiography.

Authors:  Zhenyang Zhang; Tianci Chai; Jiangbo Lin; Mingqiang Kang; Wenhua Chen; Hanfan Qiu; Zhiqiang Zou; Lei Gao; Chuangcai Yang; Jiafu Zhu
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

Review 3.  Autogenous pericardial angioplasty for thymic malignancies: a narrative review.

Authors:  Hui-Jiang Gao; Guo-Dong Shi; Mao-Jie Pan; Xiao-Tong Liu; Yu-Cheng Wei
Journal:  Mediastinum       Date:  2021-03-25

4.  Superior vena cava graft infection in thoracic surgery: a retrospective study of the French EPITHOR database.

Authors:  Laura Filaire; Olaf Mercier; Agathe Seguin-Givelet; Olivier Tiffet; Pierre Emmanuel Falcoz; Pierre Mordant; Pierre-Yves Brichon; Philippe Lacoste; Axel Aubert; Pascal Thomas; Françoise Le Pimpec-Barthes; Ioana Molnar; Magali Vidal; Marc Filaire; Géraud Galvaing
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.